We are excited to announce the groundbreaking of our new pharmaceutical manufacturing facility in Kinshasa, DRC!
This marks a monumental step in Shalina Healthcare’s ongoing commitment to delivering affordable, high-quality medicines to local communities across Africa.
With a state-of-the-art facility in the Kin Malebo, Zone économique spéciale, we are dedicated to meeting the growing healthcare needs of DRC and beyond.
This facility will manufacture over 1 billion tablets, 600 million capsules, and 20 million syrup bottles, bringing trusted brands such as Amidol, Ibucap, Anaflam, Tanzol and Hemoforce closer to patients.
The groundbreaking ceremony, held on 16 March 2026, was graced by Mr. Christian Ntumba Ngoy, DG , ACOREP, as Chief Guest, the Mayors, representatives from the Ministry of Health, Directors General from key government bodies,, reflecting strong government support.
“Today marks an important milestone in our mission to make healthcare more accessible and impactful. This new facility strengthens our resolve to empower local healthcare, create skilled employment, and contribute to the economic ecosystem of the DRC.”
– Mr. Abbas Virji, MD, Shalina Healthcare
“We are proud to support Shalina Healthcare’s initiative, which aligns with our vision of creating a sustainable healthcare landscape and improving the lives of the people in the DRC.”
– Mr. Christian Ntumba Ngoy, DG, ACOREP
We look forward to continuing our journey to bring trusted, affordable medicines closer to the people who need them the most.
Stay tuned as we continue to make strides in our mission for a healthier tomorrow!
